Researcher profile
Richard C. Kevin
Affiliations
Organizations
Hunter New England Local Health Districtauthorship · AUIo Therapeutics (United States)authorship · USNew South Wales Department of Healthauthorship · AURTI Internationalauthorship · USSt Vincent's Hospital Melbourneauthorship · AUSt Vincent's Hospital Sydneyauthorship · AUSt Vincent’s Private Hospital Sydneyauthorship · AUThe University of Sydneyauthorship · AUUNSW Sydneyauthorship · AU
Public evidence
7 connected articles
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogues2018 · bioRxivOrally administered cannabidiol does not produce false-positive tests for Δ<sup>9</sup> -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000.2022 · Europe PMCCannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.2022 · Europe PMCCannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.2019 · Europe PMCDetection of Δ<sup>9</sup> THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices.2019 · Europe PMCComposition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.2018 · Europe PMCAuthor Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.2018 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.